Equity Profile

HUM

Humana Inc.

Health CareManaged Health Care$42.0B

Apr29Wed

Post-Earnings Recap

ReportedQ1-2026Pre-Market6:00 AM EDT

Humana Beats on EPS, Stock Up 0.00%

Metric	Actual	Expected	Surprise
EPS	$10.31	$10.20	+3.46%
Revenue	N/A	$39.4B	N/A

management commentary, guidance changes, and full analysis available with Pro.

Humana Beats on EPS, Stock Up 0.00%

Key Numbers

Metric	Actual	Expected	Surprise
EPS	$10.31	$10.20	+3.46%
Revenue	N/A	$39.4B	N/A

Management Commentary

Tone: Neutral

Management expressed a cautious view on the current market environment. They acknowledged the challenges but reaffirmed their focus on operational efficiency.

Management highlighted the ongoing challenges in the healthcare sector.

They emphasized their commitment to maintaining service quality despite market pressures.

What It Means

Humana's earnings report shows a positive surprise in EPS, indicating better-than-expected profitability. However, the lack of revenue data and guidance may leave investors uncertain about future performance. The stock reaction remained flat, suggesting that investors are weighing the mixed signals from the earnings call.

Company Snapshot

Humana Inc. is a health care company that provides managed health care services....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and will show how well the company is managing costs and generating income.

$10.20

Revenue

Revenue figures will indicate the overall growth and demand for Humana's services, which is essential for assessing its market position.

$39.4B

Wall Street expectations, options signals, track record, and call prep available with Pro.

Original Pre-Earnings Preview

Context

Company Snapshot

Humana Inc. is a health care company that provides managed health care services. With a focus on Medicare and Medicaid, it plays a crucial role in the health care sector, especially as the population ages and demand for health services increases.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+9.12%

Avg Stock Reaction

-0.09%

Last Quarter Recap

In the last quarter, Humana reported an EPS of -$3.96, slightly better than expectations. The stock reacted negatively, dropping 3.25% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts are cautiously optimistic about Humana's upcoming earnings, with expectations for a solid EPS and revenue growth. However, uncertainty remains due to recent performance fluctuations.

Bull Case

If Humana exceeds EPS expectations, it could signal strong operational efficiency and growth potential, leading to a positive market reaction.

Bear Case

Conversely, if the company misses EPS estimates or shows declining revenue trends, it could raise concerns about its market competitiveness and profitability.

Key Metrics to Watch

EPS

$10.20

Earnings per share is a key indicator of profitability and will show how well the company is managing costs and generating income.

Revenue

$39.4B

Revenue figures will indicate the overall growth and demand for Humana's services, which is essential for assessing its market position.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Humana's EPS exceed the consensus estimate of $10.20?

A beat on EPS could indicate stronger-than-expected profitability and operational efficiency, which would be crucial for investor confidence.

What will be the revenue figure compared to the consensus of $39.4B?

Revenue growth is vital for assessing the company's market position and ability to attract and retain customers.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate Humana's ability to manage costs effectively, especially given its recent EPS surprises that exceeded expectations.

Supporting Evidence

Humana has an 88% EPS beat rate in recent quarters, suggesting strong operational management.

The options market is pricing a larger move than historical averages, indicating potential for a surprise.

Recent trends in the health care sector suggest increased demand for managed care services, which Humana is well-positioned to capitalize on.

Key Risk

If Humana's revenue comes in below $37.2B, it could undermine confidence in its growth trajectory.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance will be closely scrutinized as it could signal the company's ability to navigate market challenges and capitalize on growth opportunities.

Bull Confirmed If

An EPS of $10.50 or higher would confirm strong operational performance and growth potential.

Bear Confirmed If

An EPS below $9.00 would raise significant concerns about profitability and market competitiveness.

Pre-Earnings Positioning

Options Market

Implied Move

±8.55%

Historical Avg

±5.8%

Pricing rich

The options market is pricing in a significant potential move, indicating that investors expect volatility around the earnings announcement.

Options are pricing ±8.8% while HUM has averaged ±5.8% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

1.2%

30d HV

36.5%

Calls (741K)P/C Ratio: 0.39Puts (221K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Humana beats expectations, history suggests the stock could rise by around 3.1%, confirming a positive outlook for the company.

In-Line / Cautious

If results are in line with expectations, the stock may experience a muted response, reflecting cautious investor sentiment.

Miss

A miss could lead to a significant drop, with history suggesting an average decline of around 12.4%, indicating heightened concerns about the company's future.

Preparation

Congressional Activity

House & Senate STOCK Act disclosures over the trailing 6 months.

Trades

0 buys·1 sell

Members

House only

Est. Notional

$1,001.00–$15,000.00

disclosed dollar ranges

Most Active Members

R-LAJulia LetlowRep.
1

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on cost management strategies and their impact on profitability.
2Insights into membership growth in Medicare and Medicaid programs.
3Comments on competitive pressures in the managed health care market.
4Details on any changes in regulatory impacts affecting the business.
5Future guidance on revenue expectations for the upcoming quarters.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Apr27

OMABReported

Grupo Aeroportuario del Centro Norte, S.A.B. de C.V.

RecapView

Apr27

PIIReported

Company Snapshot

Humana Inc. is a health care company that provides managed health care services....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and will show how well the company is managing costs and generating income.

$10.20

Revenue

Revenue figures will indicate the overall growth and demand for Humana's services, which is essential for assessing its market position.

$39.4B

Wall Street expectations, options signals, track record, and call prep available with Pro.

Original Pre-Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+9.12%

Avg Stock Reaction

-0.09%

Last Quarter Recap

In the last quarter, Humana reported an EPS of -$3.96, slightly better than expectations. The stock reacted negatively, dropping 3.25% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts are cautiously optimistic about Humana's upcoming earnings, with expectations for a solid EPS and revenue growth. However, uncertainty remains due to recent performance fluctuations.

Bull Case

If Humana exceeds EPS expectations, it could signal strong operational efficiency and growth potential, leading to a positive market reaction.

Bear Case

Conversely, if the company misses EPS estimates or shows declining revenue trends, it could raise concerns about its market competitiveness and profitability.

Key Metrics to Watch

EPS

$10.20

Earnings per share is a key indicator of profitability and will show how well the company is managing costs and generating income.

Revenue

$39.4B

Revenue figures will indicate the overall growth and demand for Humana's services, which is essential for assessing its market position.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Humana's EPS exceed the consensus estimate of $10.20?

A beat on EPS could indicate stronger-than-expected profitability and operational efficiency, which would be crucial for investor confidence.

What will be the revenue figure compared to the consensus of $39.4B?

Revenue growth is vital for assessing the company's market position and ability to attract and retain customers.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate Humana's ability to manage costs effectively, especially given its recent EPS surprises that exceeded expectations.

Supporting Evidence

Humana has an 88% EPS beat rate in recent quarters, suggesting strong operational management.

The options market is pricing a larger move than historical averages, indicating potential for a surprise.

Recent trends in the health care sector suggest increased demand for managed care services, which Humana is well-positioned to capitalize on.

Key Risk

If Humana's revenue comes in below $37.2B, it could undermine confidence in its growth trajectory.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance will be closely scrutinized as it could signal the company's ability to navigate market challenges and capitalize on growth opportunities.

Bull Confirmed If

An EPS of $10.50 or higher would confirm strong operational performance and growth potential.

Bear Confirmed If

An EPS below $9.00 would raise significant concerns about profitability and market competitiveness.

Pre-Earnings Positioning

Options Market

Implied Move

±8.55%

Historical Avg

±5.8%

Pricing rich

The options market is pricing in a significant potential move, indicating that investors expect volatility around the earnings announcement.

Options are pricing ±8.8% while HUM has averaged ±5.8% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

1.2%

30d HV

36.5%

Calls (741K)P/C Ratio: 0.39Puts (221K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Humana beats expectations, history suggests the stock could rise by around 3.1%, confirming a positive outlook for the company.

In-Line / Cautious

If results are in line with expectations, the stock may experience a muted response, reflecting cautious investor sentiment.

Miss

A miss could lead to a significant drop, with history suggesting an average decline of around 12.4%, indicating heightened concerns about the company's future.

Preparation

Congressional Activity

House & Senate STOCK Act disclosures over the trailing 6 months.

Trades

0 buys·1 sell

Members

House only

Est. Notional

$1,001.00–$15,000.00

disclosed dollar ranges

Most Active Members

R-LAJulia LetlowRep.
1

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on cost management strategies and their impact on profitability.
2Insights into membership growth in Medicare and Medicaid programs.
3Comments on competitive pressures in the managed health care market.
4Details on any changes in regulatory impacts affecting the business.
5Future guidance on revenue expectations for the upcoming quarters.